TITLE

Coral Calcium: No Cure for Cancer; Lead Risk

PUB. DATE
July 2003
SOURCE
Environmental Nutrition;Jul2003, Vol. 26 Issue 7, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that the U.S. Federal Trade Commission has charged the promoters of a product called 'Coral Calcium Supreme' with making false and unsubstantiated claims in a 30-minute infomercial that it can cure cancer and other diseases.
ACCESSION #
10176338

 

Related Articles

  • How the Federal Trade Commission Is Fighting Cancer Treatment Scams. Kando-Pineda, Carol // Journal of Oncology Practice;Jan2010, Vol. 6 Issue 1, p50 

    The article discusses the effort made by the Federal Trade Commission (FTC) in fighting cancer treatment scams in the U.S. It notes that the FTC has launched an education campaign at the Web site located at http://ftc.gov/curious. It mentions that the FTC also sent letters to Web sites that were...

  • Court report.  // Medical Device Daily;3/3/2008, Vol. 12 Issue 42, p4 

    The article reports on the agreement of the marketers of the herbal colon-cleansing system 7 Day Miracle Cleanse Program to settle U.S. Federal Trade Commission charges that they falsely claimed that the program would cure cancer and other serious diseases. Under the settlement agreement, 7 Day...

  • Between a Reef and a Hard Place. Farer, Leslie J. // American Fitness;Jan/Feb2004, Vol. 22 Issue 1, p37 

    Presents information on coral calcium. Complaint filed by the U.S. Federal Trade Commission against Robert Barefoot, a coral calcium marketer; Importance of calcium intake; Data on daily calcium requirement; Foods containing calcium; Minerals essential to bone health.

  • Take Two and Call Congress in the Morning: How the Biologics Price Competition and Innovation Act May Fail to Prevent Systemic Abuses in the Follow-on Biologics Approval Process. Davis, Charles // George Washington Law Review Arguendo;Jul2013, Vol. 81 Issue 4, p1255 

    Biologics drugs present great promise for curing deadly diseases such as cancer or neurological disorders. These auspicious drugs are, however, inordinately expensive. The patents on many of these blockbuster biologics treatments will soon expire, creating high demand for cheap generic versions...

  • FTC alters buyer's guide rules. Lawrence, Donna // Automotive News;12/11/1995, Vol. 70 Issue 5636, p6 

    Reports that the Federal Trade Commission has made the federal Used Car Rule easier for compliance by car dealers. What the rule requires; Amendments made; Impact of changes on enforcement; Cases against dealers since rule took effect.

  • FTC offers primer on warranties.  // Black Enterprise;Jul90, Vol. 20 Issue 12, p32 

    Announces that the Federal Trade Commission, a government organization that monitors consumer complaints, has issued some guidelines on how to evaluate product warranties. They include checking to see what parts and types of repair problems are covered and what is excluded; Determine the length...

  • How the FTC serves the consumer. Oliver, D. // Consumers' Research Magazine;Aug88, Vol. 71 Issue 8, p18 

    What the Federal Trade Commission (FTC) actually does. Detailed look at antitrust, consumer protection and consumer advocacy; Examples; Effects of deregulation; Selling free market. INSET: Daniel Oliver--questions and answers..

  • Washington letter.  // DCI;Aug94, Vol. 155 Issue 2, p8 

    Reports on the concern voiced by the US Federal Trade Commission's Bureau of Competition on drug manufacturers' buyout of their generic manufacturer competitors. Views of acting deputy director Mark Whitener; Criticism of practice called `bundling.'

  • FTC ypdates marketing guidelines.  // Waste News;04/27/98, Vol. 3 Issue 50, p1 

    Presents information on the revision of its 1992 environmental marketing guides by the Federal Trade Commission. Details on the revisions; Reason for the revision; What changes were made.

Share

Read the Article

Other Topics